Komori
Techno Medica (6678) · RiskMitigated

Currency, Distributor, and Maintenance and Servicing Risks Associated with Overseas Exports

First written in FY2016. 15 of 31 entries say "Worsened", first in FY2017. Latest entry: FY2026.

31entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2017 – FY2019MitigatedFY2022-Q2 – FY2023-Q3WorsenedFY2024 – FY20252016: 12017: 120172018: 320182019: 420192020: 420202021: 420212022: 420222023: 320232024: 320242025: 220252026: 22026
Same theme, other companies
International business dependence risk from concentration of overseas bases and salesA theme 5 companies write about · 5 as a headwind · 0 as a tailwind

Techno Medica moved to the "Worse" side of this theme in 2017, 3 years before the typical company in this theme (2020).

0 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 1 percentage point from the previous fiscal year to 12.8%.」

    The overseas sales ratio fell from 13.8% in the previous fiscal year to 12.8%, slightly reducing, on a share-of-sales basis, exposure to foreign exchange, contracts with overseas customers and maintenance and servicing risks.
  2. 2026-05-11MitigatedEarnings

    「The ratio of overseas sales to total net sales declined by 1 percentage point year on year to 12.8%.」

    The decline in the overseas sales ratio slightly reduced the composition-based exposure associated with overseas expansion.
  3. FY2026-H1MitigatedAnnual report

    「Overseas sales accounted for 17.0% of total sales, a decrease of 0.1 percentage points from the same period of the previous year.」

    The overseas sales ratio fell slightly from 17.1% in the same period of the previous year to 17.0%, slightly reducing, on a share-of-sales basis, exposure to foreign exchange, contracts with overseas customers and maintenance and servicing risks.
  4. FY2025WorsenedAnnual report

    「The ratio of overseas sales to total sales increased by 4.5 percentage points from the previous fiscal year to 13.8%.」

    The overseas sales ratio rose from the previous fiscal year, increasing exposure to foreign exchange, contracts with overseas customers and maintenance and servicing risks associated with overseas expansion. This does not indicate that any specific risk has actually materialized.
  5. FY2025-H1WorsenedAnnual report

    「The ratio of overseas sales to total sales increased by 3.9 percentage points year on year to 17.1%.」

    The overseas sales ratio rose year on year to 17.1%, increasing exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  6. FY2024WorsenedAnnual report

    「Overseas sales for the fiscal year ended March 2024 were ¥955.253 million, down 13.1% year on year, and accounted for approximately 9.3% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Overseas sales fell 13.1% year on year, and their share of total sales declined to approximately 9.3%. Foreign exchange, distributor contract and maintenance and servicing risks associated with overseas expansion remain, while the performance of the export business has deteriorated.
  7. FY2024-Q3MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 1.1 percentage points year on year to 11.5%.」

    The overseas sales ratio fell from 12.6% in the same period of the previous year to 11.5%, reducing year on year, on a share-of-sales basis, exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  8. FY2024-Q1MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 0.5 percentage points year on year to 13.2%.」

    The overseas sales ratio fell from 13.7% in the same period of the previous year to 13.2%, slightly reducing, on a share-of-sales basis, exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  9. FY2023WorsenedAnnual report

    「Overseas sales for the fiscal year ended March 2023 were ¥1,099.196 million, up 6.1% year on year, and accounted for approximately 11.7% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Overseas sales and their share of total sales increased from the previous fiscal year, increasing, on a share-of-sales basis, exposure to foreign exchange, distributor contract and maintenance and servicing risks.
  10. FY2023-Q3MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 0.3 percentage points year on year to 12.6%.」

    The overseas sales ratio fell from 12.9% in the same period of the previous year to 12.6%, slightly reducing, on a share-of-sales basis, exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  11. FY2023-Q2MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 0.7 percentage points year on year to 12.6%.」

    The overseas sales ratio fell from 13.3% in the same period of the previous year to 12.6%, reducing, on a share-of-sales basis, exposure to overseas expansion-related foreign exchange, distributor contract and maintenance and servicing risks.
  12. FY2023-Q1MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 0.2 percentage points year on year to 13.7%.」

    The overseas sales ratio fell from 13.9% to 13.7% year on year, slightly reducing, on a share-of-sales basis, exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  13. FY2022MitigatedAnnual report

    「Overseas sales for the fiscal year ended March 2022 were ¥1,035.514 million, up 3.9% year on year, and accounted for approximately 10.7% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Although overseas sales increased, their share of total sales fell from approximately 11.0% in the previous fiscal year to approximately 10.7%, reducing overseas expansion exposure on a share-of-sales basis. Foreign exchange, distributor contract and maintenance and servicing risks remain.
  14. FY2022-Q3MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 0.7 percentage points year on year to 12.9%.」

    The overseas sales ratio fell from 13.6% in the same period of the previous year to 12.9%, reducing year on year, on a share-of-sales basis, exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  15. FY2022-Q2MitigatedAnnual report

    「The ratio of overseas sales to total sales decreased by 1.6 percentage points year on year to 13.3%.」

    The overseas sales ratio fell from 14.9% in the same period of the previous year to 13.3%, reducing year on year, on a share-of-sales basis, exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  16. FY2022-Q1WorsenedAnnual report

    「The ratio of overseas sales to total sales increased by 0.4 percentage points year on year to 13.9%.」

    The overseas sales ratio rose year on year, increasing year on year exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  17. FY2021WorsenedAnnual report

    「Overseas sales for the fiscal year ended March 2021 were ¥996.398 million, up 17.0% year on year, and accounted for approximately 11.0% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Overseas sales and their share of total sales increased from the previous fiscal year, increasing exposure to foreign exchange, distributor contract and maintenance and servicing risks associated with overseas expansion.
  18. FY2021-Q3WorsenedAnnual report

    「The ratio of overseas sales to total sales increased by 4.9 percentage points year on year to 13.6%.」

    The overseas sales ratio rose from 8.7% in the same period of the previous year to 13.6%, increasing year on year exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion. This is quantified by the overseas sales ratio, but does not indicate that any specific risk has actually materialized.
  19. FY2021-Q2WorsenedAnnual report

    「The ratio of overseas sales to total sales increased by 7 percentage points year on year to 14.9%.」

    The overseas sales ratio rose from 7.9% in the same period of the previous year to 14.9%, increasing year on year exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  20. FY2021-Q1WorsenedAnnual report

    「The ratio of overseas sales to total sales increased by 6.1 percentage points year on year to 13.5%.」

    The overseas sales ratio rose from 7.4% in the same period of the previous year to 13.5%, increasing year on year exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  21. FY2020MitigatedAnnual report

    「In the fiscal year ended March 2020, overseas sales amounted to ¥851.783 million, down 20.3% from the previous fiscal year, and overseas sales accounted for approximately 8.7% of total sales. Depending on future overseas expansion, we may face foreign exchange risk, risks related to contracts with overseas distributors, and risks related to maintenance and management.」

    The overseas sales ratio fell from approximately 11.4% in the previous fiscal year to 8.7%, reducing exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  22. FY2020-Q3MitigatedAnnual report

    「As a result, sales for the cumulative third quarter amounted to ¥6,915.845 million, up 12.3% year on year. The ratio of overseas sales to total sales decreased by 5.3 percentage points year on year to 8.7%.」

    The overseas sales ratio fell 5.3 percentage points year on year to 8.7%, reducing year on year exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  23. FY2020-Q2MitigatedAnnual report

    「Overseas sales accounted for 7.9% of total sales, a decrease of 6.8 percentage points from the same period of the previous year.」

    The overseas sales ratio fell from 14.7% in the same period of the previous year to 7.9%, reducing year on year exposure to foreign exchange, overseas distributor contract and maintenance and servicing risks associated with overseas expansion.
  24. FY2020-Q1MitigatedAnnual report

    「As a result, sales for the cumulative first quarter amounted to ¥2,197.701 million, up 21.1% year on year. The ratio of overseas sales to total sales decreased by 4.9 percentage points year on year to 7.4%.」

    The overseas sales ratio fell 4.9 percentage points year on year to 7.4%, reducing, on a share-of-sales basis for the most recent quarter, exposure to foreign exchange, distributor contract and maintenance and servicing risks associated with overseas exports.
  25. FY2019WorsenedAnnual report

    「Overseas sales for the fiscal year ended March 2019 were ¥1,068.395 million, up 26.2% year on year, and accounted for approximately 11.4% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Overseas sales increased 26.2% year on year, and their share of total sales rose from approximately 9.8% to 11.4%. Exposure to foreign exchange, distributor contract and maintenance and servicing risks increased.
  26. FY2019-Q3WorsenedAnnual report

    「Overseas sales accounted for 14.0% of total sales, an increase of 3.9 percentage points from the same period of the previous year.」

    The overseas sales ratio rose from 10.1% in the same period of the previous year to 14.0%, increasing exposure to the overseas business. Foreign exchange, overseas distributor contract and maintenance and servicing risks also remain.
  27. FY2019-Q2WorsenedAnnual report

    「Overseas sales accounted for 14.7% of total sales, an increase of 5.3 percentage points from the same period of the previous year.」

    The overseas sales ratio rose from 9.4% in the same period of the previous year to 14.7%, further increasing exposure to the overseas business. Foreign exchange, risks related to contracts with overseas distributors and maintenance and servicing risks remain.
  28. FY2019-Q1WorsenedAnnual report

    「As a result, operating performance for the cumulative first quarter amounted to sales of ¥1,815.394 million, up 9.3% year on year. Overseas sales accounted for 12.3% of total sales, an increase of 3.5 percentage points from the same period of the previous year.」

    The overseas sales ratio rose from 8.8% in the same period of the previous year to 12.3%, increasing exposure to the overseas business. The previously identified foreign exchange, distributor contract and maintenance and servicing risks also remain.
  29. FY2018WorsenedAnnual report

    「Overseas sales for the fiscal year ended March 2018 were ¥846.254 million, down 5.2% year on year, and accounted for approximately 9.8% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Overseas sales fell 5.2% year on year, and their share of total sales declined from approximately 10.6% to approximately 9.8%. Foreign exchange, distributor contract and maintenance and servicing risks associated with overseas expansion remain.
  30. FY2017WorsenedAnnual report

    「Overseas sales for the fiscal year ended March 2017 were ¥892.531 million, up 11.7% year on year, and accounted for approximately 10.6% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    While overseas sales and their share of total sales increased, exposure to foreign exchange, distributor contract and maintenance and servicing risks also increased.
  31. FY2016First statedAnnual report

    「Overseas sales for the fiscal year ended March 2016 were ¥799.325 million, down 11.3% year on year, and accounted for approximately 8.8% of total sales. Depending on future overseas expansion, the company may face foreign exchange risk, risks related to contracts with overseas distributors and maintenance and servicing risks.」

    Overseas sales were ¥799.325 million, accounting for approximately 8.8% of total sales, and the company cites foreign exchange, contractual and maintenance and servicing risks associated with overseas expansion.
Moved together

"Expanding Market Share of Blood Collection Tube Preparation Equipment" moved the same way as this thread, in the same document, in 18 of its 31 moves.

181715131210★123456
  1. ★This thread
  2. 1Expanding Market Share of Blood Collection Tube Preparation Equipment18×
  3. 2Expansion of Recurring Sales through Related Consumables and Maintenance Services17×
  4. 3Achieving Stable Growth in Net Sales and a 20% Ordinary Profit Margin on Net Sales15×
  5. 4Uncertainty in the Global Economy Surrounding the Slowdown in Emerging-Market Economies and the UK's Withdrawal from the EU13×
  6. 5Sound Financing Based on Operating Cash Flow12×
  7. 6Equipment sales weighted toward the second half and fourth quarter10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Techno Medica yet. It last moved in the Earnings of 2026-05-11: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.